Brenda Martínez-González

Mrs. Brenda Martínez-González

National Center for Biotechnology, Madrid, Spain
+1
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
EDEsteban Domingo
Esteban Domingo
MSMaría Eugenia Soria
María Eugenia Soria
IGIsabel Gallego
Isabel Gallego
AÁAna Isabel de Ávila
Ana Isabel de Ávila
CGCarlos García-Crespo
Carlos García-Crespo
CPCelia Perales
Celia Perales

8 June 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
BMBrenda Martínez-González
Brenda Martínez-González
MSMaría Eugenia Soria
María Eugenia Soria
LVLucía Vázquez-Sirvent
Lucía Vázquez-Sirvent
CFCristina Ferrer-Orta
Cristina Ferrer-Orta
RLRebeca Lobo-Vega
Rebeca Lobo-Vega
CPCelia Perales
Celia Perales
Populations of RNA viruses are composed of complex and dynamic mixtures of variant genomes that are termed mutant spectra or mutant clouds. This applies also to SARS-CoV-2, and mutations that are detected at low frequency in an infected individual can be dominant (represented in the consensus sequence) in subsequent variants of interest or variants of concern. Here we briefly review the main conclusions of our work on mutant spectrum characterization of hepatitis C virus (HCV) and SARS-CoV-2 at the nucleotide and amino acid levels and address the following two new questions derived from previous results: (i) how is the SARS-CoV-2 mutant and deletion spectrum composition in diagnostic samples, when examined at progressively lower cut-off mutant frequency values in ultra-deep sequencing; (ii) how the frequency distribution of minority amino acid substitutions in SARS-CoV-2 compares with that of HCV sampled also from infected patients. The main conclusions are the following: (i) the number of different mutations found at low frequency in SARS-CoV-2 mutant spectra increases dramatically (50- to 100-fold) as the cut-off frequency for mutation detection is lowered from 0.5% to 0.1%, and (ii) that, contrary to HCV, SARS-CoV-2 mutant spectra exhibit a deficit of intermediate frequency amino acid substitutions. The possible origin and implications of mutant spectrum differences among RNA viruses are discussed.

21 September 2021 in Access Microbiology
Verified
Journal Article
Open access
MSMaría Eugenia Soria
María Eugenia Soria
MCMarta Corton
Marta Corton
BMBrenda Martínez-González
Brenda Martínez-González
RLRebeca Lobo-Vega
Rebeca Lobo-Vega
LVLucía Vázquez-Sirvent
Lucía Vázquez-Sirvent
CPCelia Perales
Celia Perales
COVID-19 severity and progression are determined by several host and virological factors that may influence the final outcome of SARS-CoV-2-infected patients. The objective of this work was to determine a possible association between viral load, obtained from nasopharyngeal swabs, and the severity of the infection in a cohort of 448 SARS-CoV-2-infected patients from a hospital in Madrid during the first outbreak of the pandemic in Spain. To perform this, we clinically classified patients as mild, moderate and severe COVID-19 according to a number of clinical parameters such as hospitalization requirement, need of oxygen therapy, admission to intensive care units and/or death. Also, Ct values were determined using SARS-CoV-2-specific oligonucleotides directed to ORF1ab. Here we report a statistically significant association between viral load and disease severity, a high viral load being associated with worse clinical prognosis, independently of several previously identified risk factors such as age, sex, hypertension, cardiovascular disease, diabetes, obesity and lung disease (asthma and chronic obstructive pulmonary disease). The data presented here reinforce viral load as a potential biomarker for predicting disease severity in SARS-CoV-2-infected patients. It is also an important parameter in viral evolution since it relates to the numbers and types of variant genomes present in a viral population, a potential determinant of disease progression.

28 February 2020 in Journal of Virology
Verified
Journal Article
Closed access
IGIsabel Gallego
Isabel Gallego
MSMaría Eugenia Soria
María Eugenia Soria
CGCarlos García-Crespo
Carlos García-Crespo
QCQian Chen
Qian Chen
PMPatricia Martínez-Barragán
Patricia Martínez-Barragán
EDEsteban Domingo
Esteban Domingo
The study shows that extensive replication of an RNA virus in a constant biological environment does not limit exploration of sequence space and adaptive options. There was no convergence toward a restricted set of adapted genomes. Mutational waves and mutant spectrum broadening affected infectious genomes. Therefore, profound modifications of mutant spectrum composition and consensus sequence diversification are not exclusively dependent on environmental alterations or the intervention of population bottlenecks.

Verified
Journal Article
Open access
PDF file
MLMeritxell Llorens-Revull
Meritxell Llorens-Revull
BMBrenda Martínez-González
Brenda Martínez-González
JQJosep Quer
Josep Quer
JEJuan Ignacio Esteban
Juan Ignacio Esteban
GNGonzalo Núñez-Moreno
Gonzalo Núñez-Moreno
Maria I. CostafredaMaria I. Costafreda
Maria I. Costafreda
MicroRNAs (miRNAs) encapsulated in extracellular vesicles (EVs) are potential diagnostic and prognostic biomarkers. However, discrepancies in miRNA patterns and their validation are still frequent due to differences in sample origin, EV isolation, and miRNA sequencing methods. The aim of the present study is to find a reliable EV isolation method for miRNA sequencing, adequate for clinical application. To this aim, two comparative studies were performed in parallel with the same human plasma sample: (i) isolation and characterization of EVs obtained using three procedures: size exclusion chromatography (SEC), iodixanol gradient (GRAD), and its combination (SEC+GRAD) and (ii) evaluation of the yield of miRNA sequences obtained using NextSeq 500 (Illumina) and three miRNA library preparation protocols: NEBNext, NEXTFlex, and SMARTer smRNA-seq. The conclusion of comparison (i) is that recovery of the largest amount of EVs and reproducibility were attained with SEC, but GRAD and SEC+GRAD yielded purer EV preparations. The conclusion of (ii) is that the NEBNext library showed the highest reproducibility in the number of miRNAs recovered and the highest diversity of miRNAs. These results render the combination of GRAD EV isolation and NEBNext library preparation for miRNA retrieval as adequate for clinical applications using plasma samples.

18 November 2020 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
MSMaría Eugenia Soria
María Eugenia Soria
CGCarlos García-Crespo
Carlos García-Crespo
BMBrenda Martínez-González
Brenda Martínez-González
LVLucía Vázquez-Sirvent
Lucía Vázquez-Sirvent
RLRebeca Lobo-Vega
Rebeca Lobo-Vega
CPCelia Perales
Celia Perales
Despite the high virological response rates achieved with current directly acting antiviral agents (DAAs) against hepatitis C virus (HCV), around 2% to 5% of treated patients do not achieve a sustained viral response. The identification of amino acid substitutions associated with treatment failure requires analytical designs, such as subtype-specific ultradeep sequencing (UDS) methods, for HCV characterization and patient management. Using this procedure, we have identified six highly represented amino acid substitutions (HRSs) in NS5A and NS5B of HCV, which are not bona fide resistance-associated substitutions (RAS), from 220 patients who failed therapy.